Glucagon-based Therapy for People with Diabetes and Obesity: What is the Sweet Spot?
PEPTIDES（2024）
Key words
Metabolic dysfunction-associated steatotic liver,disease (MASLD),Type 2 diabetes,Glucagon,Glucagon-like peptide-1,Glucose-dependent insulinotropic polypeptide,Obesity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined